Renal Function at Hospital Admission and Mortality Due to Acute Kidney Injury after Myocardial Infarction


Autoria(s): Bruetto, Rosana G.; Rodrigues, Fernando B.; Torres, Ulysses S.; Otaviano, Ana P.; Zanetta, Dirce Maria Trevisan; Burdmann, Emmanuel A.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

23/10/2013

23/10/2013

2012

Resumo

Background: The role of an impaired estimated glomerular filtration rate (eGFR) at hospital admission in the outcome of acute kidney injury (AKI) after acute myocardial infarction (AMI) has been underreported. The aim of this study was to assess the influence of an admission eGFR<60 mL/min/1.73 m(2) on the incidence and early and late mortality of AMI-associated AKI. Methods: A prospective study of 828 AMI patients was performed. AKI was defined as a serum creatinine increase of >= 50% from the time of admission (RIFLE criteria) in the first 7 days of hospitalization. Patients were divided into subgroups according to their eGFR upon hospital admission (MDRD formula, mL/min/1.73 m(2)) and the development of AKI: eGFR >= 60 without AKI, eGFR<60 without AKI, eGFR >= 60 with AKI and eGFR<60 with AKI. Results: Overall, 14.6% of the patients in this study developed AKI. The admission eGFR had no impact on the incidence of AKI. However, the admission eGFR was associated with the outcome of AMI-associated AKI. The adjusted hazard ratios (AHR, Cox multivariate analysis) for 30-day mortality were 2.00 (95% CI 1.11-3.61) for eGFR, 60 without AKI, 4.76 (95% CI 2.45-9.26) for eGFR >= 60 with AKI and 6.27 (95% CI 3.20-12.29) for eGFR, 60 with AKI. Only an admission eGFR of <60 with AKI was significantly associated with a 30-day to 1-year mortality hazard (AHR 3.05, 95% CI 1.50-6.19). Conclusions: AKI development was associated with an increased early mortality hazard in AMI patients with either preserved or impaired admission eGFR. Only the association of impaired admission eGFR and AKI was associated with an increased hazard for late mortality among these patients.

Foundation for the Support of Research in the State of Sao Paulo (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP), Brazil

Foundation for the Support of Research in the State of Sao Paulo (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP), Brazil

National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq), Brazil

National Council for Scientific and Technological Development (CNPq, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), Brazil

Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil

Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil [0076/2007]

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Foundation for the Support of Research in the State of Sao Paulo)

Foundation for the Support of Research in the State of Sao Paulo (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP) [2008/57115-6]

Identificador

PLOS ONE, SAN FRANCISCO, v. 7, n. 4, supl. 1, Part 2, pp. 55-60, APR 23, 2012

1932-6203

http://www.producao.usp.br/handle/BDPI/35647

10.1371/journal.pone.0035496

http://dx.doi.org/10.1371/journal.pone.0035496

Idioma(s)

eng

Publicador

PUBLIC LIBRARY SCIENCE

SAN FRANCISCO

Relação

PLOS ONE

Direitos

openAccess

Copyright PUBLIC LIBRARY SCIENCE

Palavras-Chave #ACUTE CORONARY SYNDROME #GLOMERULAR-FILTRATION-RATE #LONG-TERM PROGNOSIS #CARDIAC-SURGERY #SERUM CREATININE #RISK-FACTOR #OUTCOMES #DISEASE #FAILURE #ASSOCIATION #MULTIDISCIPLINARY SCIENCES
Tipo

article

original article

publishedVersion